Xilio Therapeutics, Inc. - stock earnings
XLO Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q3 | -16.7 million USD | ? USD |
| 2023Q2 | -19.4 million USD | ? USD |
| 2023Q1 | -21.3 million USD | ? USD |
| 2022Q4 | -21.8 million USD | ? USD |
| 2022Q3 | -19.4 million USD | ? USD |
| 2022Q2 | -24.7 million USD | ? USD |
| 2022Q1 | -21.5 million USD | ? USD |
| 2021Q4 | -19.7 million USD | ? USD |
| 2021Q3 | -16.3 million USD | ? USD |
| 2021Q2 | -23.2 million USD | ? USD |
| 2021Q1 | -16.7 million USD | ? USD |
| 2020Q4 | -20.8 million USD | ? USD |
| 2020Q3 | -14.8 million USD | ? USD |
XLO Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -81.2 million USD | ? USD |
| 2022 | -87.3 million USD | ? USD |
| 2021 | -74.3 million USD | ? USD |
| 2020 | -55.2 million USD | ? USD |
| 2019 | -17.3 million USD | ? USD |
XLO
Price: $1.05
52 week price:
Earnings Per Share: -2.96 USD
P/E Ratio: -0.22
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 18100
Market Capitalization: 35.2 million